Usana Health Sciences Inc
USNA
Get informed when a big investor buys or sells
+ FollowMarket Cap$285.62M
Close$
$60.13
341.2% upside
Current Fair Value
341.2% upsideUndervalued by 341.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $285.62 Million |
|---|---|
| Enterprise Value | $136.87 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.58 |
| Beta | 0.73 |
| Outstanding Shares | 18,486,000 |
Return
| Return on Equity | -4.08% |
|---|---|
| Return on Assets | -3.00% |
| Return on Invested Capital | 2.26% |
Valuation & Multiples
| P/E Ratio | -12.82 |
|---|---|
| PEG | 3.99 |
| Price to Sales | 0.28 |
| Price to Book Ratio | 0.43 |
| Enterprise Value to Revenue | 0.15 |
| Enterprise Value to EBIT | 9.73 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$0.43
Average shareholder expectationRevenue Estimate
$235.00 M
Average shareholder expectationNext Earnings Call
Expected Date
October 28, 2026
EPS Estimate
$0.11
Average shareholder expectationRevenue Estimate
$219.02 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 18.23%▼ 37.92% |
|---|---|
| Total Invested | $71.63M▼ 60.12% |
| Investors Holding | 45▼ 95.00% |
ESG Score
No data
About Usana Health Sciences Inc
CEO: Kevin Guest